- Home
- NAAS vs INBS Comparison
NAAS vs INBS Comparison
Compare NAAS & INBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NAAS
- INBS
- Stock Information
- Founded
- NAAS 2019
- INBS 2016
- Country
- NAAS China
- INBS United States
- Employees
- NAAS N/A
- INBS N/A
- Industry
- NAAS Other Specialty Stores
- INBS Medical Specialities
- Sector
- NAAS Consumer Discretionary
- INBS Health Care
- Exchange
- NAAS Nasdaq
- INBS Nasdaq
- Market Cap
- NAAS 8.3M
- INBS 8.7M
- IPO Year
- NAAS 2017
- INBS N/A
- Fundamental
- Price
- NAAS $1.06
- INBS $1.66
- Analyst Decision
- NAAS
- INBS
- Analyst Count
- NAAS 0
- INBS 0
- Target Price
- NAAS N/A
- INBS N/A
- AVG Volume (30 Days)
- NAAS 209.1K
- INBS 137.5K
- Earning Date
- NAAS 07-23-2025
- INBS 05-13-2025
- Dividend Yield
- NAAS N/A
- INBS N/A
- EPS Growth
- NAAS N/A
- INBS N/A
- EPS
- NAAS N/A
- INBS N/A
- Revenue
- NAAS $43,258,393.00
- INBS $2,936,472.00
- Revenue This Year
- NAAS $19.53
- INBS $280.88
- Revenue Next Year
- NAAS $151.36
- INBS $126.26
- P/E Ratio
- NAAS N/A
- INBS N/A
- Revenue Growth
- NAAS 50.34
- INBS 3.87
- 52 Week Low
- NAAS $1.01
- INBS $1.00
- 52 Week High
- NAAS $41.80
- INBS $3.00
- Technical
- Relative Strength Index (RSI)
- NAAS 33.14
- INBS 67.48
- Support Level
- NAAS $1.01
- INBS $1.35
- Resistance Level
- NAAS $1.24
- INBS $1.68
- Average True Range (ATR)
- NAAS 0.09
- INBS 0.10
- MACD
- NAAS 0.04
- INBS 0.04
- Stochastic Oscillator
- NAAS 16.92
- INBS 92.31
About NAAS NaaS Technology Inc.
Naas Technology Inc is an electric vehicle charging service provider in China, whose vision is to power the world with carbon-neutral energy. It offers an integrated set of online solutions to charging station operators. wide range of offline services that simplify the daily operations of charging station operators, and of non-charging services such as food and beverage services to station operators.
About INBS Intelligent Bio Solutions Inc.
Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company business through two operating segments include Commercially available Intelligent Fingerprinting Products (IFPG or IFPG segment) and, Development Stage Biosensor Platform Technology (BPT segment).